神经炎症进展与静脉溶栓患者临床预后相关
这项前瞻性多中心队列研究纳入743例接受静脉溶栓的急性缺血性卒中患者,检测溶栓前及溶栓后24小时血清GFAP水平。结果显示,溶栓后GFAP升高与梗死体积增大、神经功能评分升高及不良预后独立相关,且基线外周炎症指标与GFAP升高相关。
要点
- 静脉溶栓后24小时内GFAP升高提示神经炎症进展,与不良预后独立相关。
- 基线外周炎症水平越高,溶栓后GFAP升高越明显。
- 血清GFAP变化可作为溶栓后神经炎症进展的监测指标。
核心结论
- 静脉溶栓后24小时内GFAP升高与临床结局独立相关,基线外周炎症越高GFAP升高越明显。
研究设计与样本
- 前瞻性队列研究,纳入2016年9月至2023年4月中国16个中心接受静脉溶栓的急性缺血性卒中患者743例。
- 在溶栓前(基线,发病4.5小时内)和溶栓后24小时测量血清GFAP水平,计算GFAP变化值。
主要发现
- 溶栓后GFAP水平显著升高,提示神经炎症进展。
- GFAP升高与较大梗死体积独立相关(β=30.965,95%CI 19.185-42.745,P<0.001)。
- GFAP升高与24小时NIHSS评分较高独立相关(β=2.632,95%CI 1.644-3.620,P<0.001)。
- GFAP升高与7天NIHSS评分较高独立相关(β=3.298,95%CI 2.179-4.417,P<0.001)。
- GFAP升高与不良结局独立相关(OR=3.631,95%CI 2.159-6.106,P<0.001)。
关键数值与推荐
- 不良结局定义为3个月改良Rankin量表评分≥2分。
- 基线外周炎症指标与GFAP升高显著相关。
临床怎么用
- 监测静脉溶栓后24小时内血清GFAP变化可能有助于评估神经炎症进展和预后。
- 基线外周炎症指标可能提示溶栓后神经炎症加重的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent research has shown that neuroinflammation progresses rapidly within a few hours after stroke; however, the relationship between its progression and clinical outcomes remains unclear. Therefore, this study aimed to investigate the effect of neuroinflammation, measured by serum GFAP (glial fibrillary acidic protein), on patient outcomes, as well as the influence of baseline peripheral inflammation on the progression of neuroinflammation. METHODS: This prospective cohort study enrolled patients with acute ischemic stroke who received intravenous thrombolysis (IVT) between September 2016 and April 2023 across 16 centers in China. Serum GFAP levels were measured before (baseline, within 4.5 hours of onset) and at 24 hours after IVT. GFAP changes were determined by subtracting baseline levels from those measured 24 hours post-IVT. Outcome measures included final infarct volume during hospitalization, National Institutes of Health Stroke Scale scores at 24 hours and 7 days post-IVT, early neurological deterioration within 24 hours, delayed neurological deterioration within 7 days, and 3-month modified Rankin Scale scores. A modified Rankin Scale score of ≥2 was classified as an unfavorable outcome. Peripheral inflammation indicators were measured at baseline. Binary logistic and linear regressions were used as the main statistical methods. RESULTS: Overall, 743 patients were included. A significant increase in GFAP levels was observed, indicating progression of neuroinflammation. Regression analyses revealed that increased GFAP after IVT was independently associated with larger infarct volume (β, 30.965 [95% CI, 19.185-42.745]; P<0.001), higher 24-hour and 7-day National Institutes of Health Stroke Scale scores (24-hour: β, 2.632 [95% CI, 1.644-3.620]; P<0.001; 7-day: β, 3.298 [95% CI, 2.179-4.417]; P<0.001), and unfavorable outcomes (odds ratio, 3.631, [95% CI, 2.159-6.106]; P<0.001). Furthermore, baseline peripheral inflammation, assessed using peripheral inflammation indicators, was significantly associated with elevated GFAP levels. CONCLUSIONS: The increase in GFAP levels over the first 24 hours after IVT is independently associated with clinical outcomes, with higher baseline peripheral inflammation correlating with greater GFAP elevation during that period.
引用
- Qu Y, Zhou T, Li C, et al. Progression of Neuroinflammation Is Associated With Clinical Prognosis of Patients Undergoing Intravenous Thrombolysis. Stroke. 2025. PMID: 41416382. doi:10.1161/STROKEAHA.125.053004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。